Research & Literature

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.

Saiag P, Grob JJ, Lebbe C, et al.

European journal of cancer (Oxford, England : 1990) 2015; (51(17)):2604-8.

A Novel Chromosomal Translocation Associated With COL1A2-PDGFB Gene Fusion in Dermatofibrosarcoma Protuberans: PDGF Expression as a New Diagnostic Tool.

Nakamura I, Kariya Y, Okada E, et al.

JAMA dermatology 2015; (151(12)):1330-1337 doi:10.1001/jamadermatol.2015.2389.

Wide Local Excision for Dermatofibrosarcoma Protuberans: A Single-Center Series of 90 Patients.

Kim BJ, Kim H, Jin US, et al.

BioMed research international 2015; (2015()):642549 doi:10.1155/2015/642549.

Role of diffusion-weighted magnetic resonance imaging in the evaluation of scalp dermatofibrosarcoma protuberans.

Van Steenkiste E, Van Laethem A, Biesemans G, Pans S

International journal of dermatology 2016; (55(2)):226-31 doi:10.1111/ijd.13050.

Dermatofibrosarcoma Protuberans: The role of tissue expansion in reconstructive surgery of the scalp.

Maguire R, Nikolorakos D, Lam A

International journal of surgery case reports 2016; (19()):137-9.

Bednar Tumor: An Uncommon Entity.

Amonkar GP, Rupani A, Shah A, Deshpande R

Dermatopathology (Basel, Switzerland) 2016; (3(2)):36-8 doi:10.1159/000445714.

Dermatofibrosarcoma Protuberans.

Reha J, Katz SC

The Surgical clinics of North America 2016; (96(5)):1031-46.

Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22).

Saab J, Rosenthal IM, Wang L, et al.

The American Journal of dermatopathology 2017; (39(4)):304-309 doi:10.1097/DAD.0000000000000746.

[A tumour mistaken for a scar].

van den Brand AC, Erceg A

Nederlands tijdschrift voor geneeskunde 2017; (161()):D707.

Wide local excision vs. Mohs Tübingen technique in the treatment of dermatofibrosarcoma protuberans: a two-centre retrospective study and literature review.

Veronese F, Boggio P, Tiberio R, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2017; (31(12)):2069-2076 doi:10.1111/jdv.14378.

Recurrent dermatofibrosarcoma protuberans treated with neoadjuvant imatinib mesylate followed by Mohs micrographic surgery.

Fontecilla NM, Kittler NW, Geskin L, et al.

JAAD case reports 2017; (3(6)):467-469 doi:10.1016/j.jdcr.2017.06.019.

Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.

Koseła-Paterczyk H, Rutkowski P

Expert review of anticancer therapy 2017; (17(12)):1107-1116 doi:10.1080/14737140.2017.1390431.

Relapse in dermatofibrosarcoma protuberans: A histological and molecular analysis.

Molina AS, Duprat Neto JP, Bertolli E, et al.

Journal of surgical oncology 2018; (117(5)):845-850 doi:10.1002/jso.25039.

Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis.

Hall DL, Luberto CM, Philpotts LL, et al.

Psycho-oncology 2018; (27(11)):2546-2558 doi:10.1002/pon.4757.

Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.

Dadone-Montaudié B, Alberti L, Duc A, et al.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018; (31(11)):1683-1693 doi:10.1038/s41379-018-0089-4.

Dermatofibrosarcoma protuberans: A clinical analysis.

Lyu A, Wang Q

Oncology letters 2018; (16(2)):1855-1862 doi:10.3892/ol.2018.8802.

Review of the medical literature and assessment of current utilization patterns regarding the use of two common fluorescence in situ hybridization assays in the diagnosis of dermatofibrosarcoma protuberans and clear cell sarcoma.

Linos K, Kozel JA, Hurley MY, Andea AA

Journal of cutaneous pathology 2018; (45(12)):905-913 doi:10.1111/cup.13345.

Dermatofibrosarcoma Protuberans Secondary to a Decorative Tattoo: An Isotattootopic Response?

Lastrucci I, Gunnella S, Pileri A, et al.

Indian journal of dermatology 2018; (63(5)):439-440 doi:10.4103/ijd.IJD_265_17.

Guidelines for Diagnosis and Treatment of Cutaneous Sarcomas: Dermatofibrosarcoma Protuberans.

Llombart B, Serra C, Requena C, et al.

Actas dermo-sifiliograficas 2018; (109(10)):868-877 doi:10.1016/j.ad.2018.05.006.

[Perianal dermatofibrosarcoma protuberans: a case report, review and update].

Velasco Albendea FJ, Doña Girón J, Blanco Villar ML, et al.

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 2019; (52(1)):62-68 doi:10.1016/j.patol.2018.02.004.

Risk-stratified surveillance in dermatofibrosarcoma protuberans: Less is more.

Gladdy RA, Wunder JS

Cancer 2019; (125(5)):670-672 doi:10.1002/cncr.31922.

A case of aggressive giant dermatofibrosarcoma protuberance occurring in the parotid gland.

Adilbay D, Khozhamkul F, Toiynbekova S, Ahmetov D

International journal of surgery case reports 2019; (55()):58-61 doi:10.1016/j.ijscr.2018.12.006.

Dermatofibrosarcoma protuberans: our 10-year experience on 80 patients.

Zhou X, Sun D, Liu Y, et al.

The Journal of dermatological treatment 2020; (31(6)):554-558 doi:10.1080/09546634.2019.1622629.

S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018.

Ugurel S, Kortmann RD, Mohr P, et al.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2019; (17(6)):663-668 doi:10.1111/ddg.13849_g.

Dermatofibrosarcoma Protuberans Re-excision and Recurrence Rates in the Netherlands Between 1989 and 2016.

van Lee CB, Kan WC, Gran S, et al.

Acta dermato-venereologica 2019; (99(12)):1160-1165 doi:10.2340/00015555-3287.

Atrophic dermatofibrosarcoma protuberans: a clinicopathological study of 16 cases.

Xu S, Zhao L, Wang J

Pathology 2019; (51(6)):615-620 doi:10.1016/j.pathol.2019.06.002.

Dermatofibrosarcoma Protuberans.

Allen A, Ahn C, Sangüeza OP

Dermatologic clinics 2019; (37(4)):483-488 doi:10.1016/j.det.2019.05.006.

Development and usability evaluation of an online self-management intervention for fear of cancer recurrence (iConquerFear).

Smith AB, Bamgboje-Ayodele A, Butow P, et al.

Psycho-oncology 2020; (29(1)):98-106 doi:10.1002/pon.5218.

Primary scalp dermatofibrosarcoma protuberans with periosteal involvement.

Steele L, Mitchell C, Sharma S, Keohane SG

Clinical and experimental dermatology 2020; (45(5)):661-663 doi:10.1111/ced.14166.

Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: a case report.

Hrudka J, Charvát M, Grossmann P, Kinkor Z

Ceskoslovenska patologie 2020; (56(2)):89-93.

Pigmented Dermatofibrosarcoma Protuberans: Description of a pediatric case.

Nieto-Benito LM, Berenguer-Fröhner B, Parra-Blanco V, Campos-Domínguez M

Revista chilena de pediatria 2020; (91(1)):99-104 doi:10.32641/rchped.v91i1.1303.

Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: A tale of unbridled expansion.

Reid AT, Berger A, Johnson-Jahangir H

JAAD case reports 2020; (6(10)):1006-1008 doi:10.1016/j.jdcr.2020.07.053.

A Bednar tumor in a healthy woman.

Yamada T, Ohwada S

Clinical case reports 2020; (8(10)):2076-2077 doi:10.1002/ccr3.3029.

Dermatofibrosarcoma protuberans (DFSP) in children: A combined multidisciplinary approach.

Sleiwah A, Psomadakis C, Craythorne E, et al.

Pediatric dermatology 2021; (38(1)):233-236 doi:10.1111/pde.14425.

Treatment of dermatofibrosarcoma of the head and neck with Mohs surgery with paraffin sections.

González A, Etchichury D, Rivero JM, Adamo L

Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2021; (74(5)):1061-1070 doi:10.1016/j.bjps.2020.10.062.

Clinicopathological features of fibrosarcomatous dermatofibrosarcoma protuberans and the construction of a back-propagation neural network recognition model.

Li Y, Liang J, Xu X, et al.

Orphanet journal of rare diseases 2021; (16(1)):48 doi:10.1186/s13023-021-01698-4.

Neoadjuvant imatinib as treatment preceding surgery for vulvar dermatofibrosarcoma protuberans.

Merlo G, Cozzani E, Comandini D, et al.

Dermatologic therapy 2021; (34(2)):e14860 doi:10.1111/dth.14860.

Examining fear of cancer recurrence in primary brain tumor patients and their caregivers using the Actor-Partner Interdependence Model.

Braun SE, Aslanzadeh FJ, Thacker L, Loughan AR

Psycho-oncology 2021; (30(7)):1120-1128 doi:10.1002/pon.5659.

Determination of COL1A1-PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberans.

Zhu R, Yan J, Li B, et al.

Experimental and molecular pathology 2021; (122()):104672 doi:10.1016/j.yexmp.2021.104672.

Dermatofibrosarcoma protuberans with platelet-derived growth factor-D rearrangement; two cases with morphologically distinct presentations.

Campbell K, Bridge JA, DiMaio D, et al.

Journal of cutaneous pathology 2022; (49(3)):274-277 doi:10.1111/cup.14148.

Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms.

Papke DJ, Hornick JL

Histopathology 2022; (80(1)):216-232 doi:10.1111/his.14450.

Preoperative Risk Factors for Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans.

Mallett KE, Almubarak S, Claxton RM, et al.

Anticancer research 2022; (42(1)):105-108 doi:10.21873/anticanres.15463.

Facial subcutaneous dermatofibrosarcoma protuberans treated with imatinib and monitored with magnetic resonance: A therapeutic alternative for unresectable cases.

Navarrete-Dechent C, Shah K, Mori S, et al.

Dermatologic therapy 2022; (35(6)):e15446 doi:10.1111/dth.15446.

Dermatofibrosarcoma Protuberans in Children.

Sleiwah A, Wright TC, Chapman T, et al.

Current treatment options in oncology 2022; (23(6)):843-854 doi:10.1007/s11864-022-00979-9.

Dermatofibrosarcoma Protuberans Of Trunk In A Male Patient.

Hashmi JZ, Ghafoor A, Rauf Khan Hiraj MU, Chaudhary WA

Journal of Ayub Medical College, Abbottabad : JAMC 2022; (34(2)):364-365 doi:10.55519/JAMC-02-8960.

Therapeutic intervention in fear of cancer recurrence in adult oncology patients: a systematic review.

Paperák P, Javůrková A, Raudenská J

Journal of cancer survivorship : research and practice 2023; (17(4)):1017-1035 doi:10.1007/s11764-022-01277-x.

Dermatofibrosarcoma protuberans of the face: A clinicopathologic and molecular study of 34 cases.

Han Q, Chen M, Yang J, et al.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2022; (20(11)):1463-1473 doi:10.1111/ddg.14882.

Review of dermatofibrosarcoma protuberans.

Lim SX, Ramaiya A, Levell NJ, Venables ZC

Clinical and experimental dermatology 2023; (48(4)):297-302 doi:10.1093/ced/llac111.

Outcome After Surgical Treatment of Dermatofibrosarcoma Protuberans (DFSP): Does it Require Extensive Follow-up and What is an Adequate Resection Margin?

Alshaygy I, Mattei JC, Basile G, et al.

Annals of surgical oncology 2023; (30(5)):3106-3113 doi:10.1245/s10434-022-12953-8.

Dermatofibrosarcoma Protuberans Over Right Lumbar Region: A Case Report.

Pathak B, Maimoon S

Cureus 2023; (15(1)):e33208 doi:10.7759/cureus.33208.

Surgical management of dermatofibrosarcoma protuberans.

Rust DJ, Kwinta BD, Geskin LJ, et al.

Journal of surgical oncology 2023; (128(1)):87-96 doi:10.1002/jso.27258.

Dermatofibrosarcoma protuberans of the scalp: Surgical management in a multicentric series of 11 cases and systematic review of the literature.

Kuhlmann C, Ehrl D, Taha S, et al.

Surgery 2023; (173(6)):1463-1475 doi:10.1016/j.surg.2023.02.026.

COL1A1-PDGFB Fusion Gene Detection Through Bulk RNA-Seq and Transcriptomic Features of Dermatofibrosarcoma Protuberans.

Peng R, Zhang G, Li H

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2023; (49(5S)):S27-S33 doi:10.1097/DSS.0000000000003771.

Dermatofibrosarcoma Protuberans of the Scalp Mimicking Trichilemmal Cyst: A Case Report.

Alsharif TH, Gronfula A, Alanazi AT, et al.

Cureus 2023; (15(5)):e39315 doi:10.7759/cureus.39315.

Survival Outcomes and Prognostic Factors of Dermatofibrosarcoma Protuberans: A Population-Based Retrospective Cohort Analysis.

Chen S, Xiong L, Zhao L, et al.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2023; (49(9)):825-831 doi:10.1097/DSS.0000000000003853.

Dermatofibrosarcoma protuberans: A rare presentation in the scalp. Case report.

Aleem A, Rajendran B, Aleem K

Stomatologija 2023; (25(1)):26-28.

Targeted therapy and immunotherapy for orbital and periorbital tumors: a major review.

Lee Boniao E, Allen RC, Sundar G

Orbit (Amsterdam, Netherlands) 2024; (43(5)):656-673 doi:10.1080/01676830.2023.2256848.

Dermatofibrosarcoma Protuberans: A Surgeon's Enigma.

Gangadhar SM, Yadav M, Mandal NS

Cureus 2023; (15(8)):e44144 doi:10.7759/cureus.44144.

Fibrosarcomatous dermatofibrosarcoma protuberans: a rapidly growing 30 cm mass on the posterior scalp.

Lerttiendamrong B, Annoppornchai P, Promniyom P

Asian biomedicine : research, reviews and news 2023; (17(4)):200-205 doi:10.2478/abm-2023-0060.

Incidence and Survival Outcomes of Dermatofibrosarcoma Protuberans From 2000 to 2020: A Population-Based Retrospective Cohort Analysis.

Xiong DD, Bordeaux JS

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2023; (49(12)):1096-1103 doi:10.1097/DSS.0000000000004018.

Comparing Mohs micrographic surgery and wide local excision in the management of head and neck dermatofibrosarcoma protuberans: a scoping review.

Sanabria A, Pinillos P, Chiesa-Estomba C, et al.

The Journal of dermatological treatment 2024; (35(1)):2295816 doi:10.1080/09546634.2023.2295816.

Dermatofibrosarcoma Protuberans: A Study of 148 Patients.

Marcoval J, Moreno-Vílchez C, Torrecilla-Vall-Llosera C, et al.

Dermatology (Basel, Switzerland) 2024; (240(3)):487-493 doi:10.1159/000536172.

A Rare Case of Dermatofibrosarcoma in a Pediatric Patient.

Martinez PF, Richardson S, Bakovic M, et al.

Plastic and reconstructive surgery. Global open 2024; (12(1)):e5546 doi:10.1097/GOX.0000000000005546.

COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.

Rota S, Franza A, Fabbroni C, et al.

Cancer reports (Hoboken, N.J.) 2024; (7(2)):e1969 doi:10.1002/cnr2.1969.

Bednar's tumor at right shoulder in an adult male: a case report of a rare entity.

Acharya B, Yadav DK, Chetry A, et al.

Annals of medicine and surgery (2012) 2024; (86(2)):1196-1199 doi:10.1097/MS9.0000000000001672.

Guidelines needed for the management of fear of cancer recurrence in adult survivors of cancer in the United States: A consensus statement.

Hall DL, Wagner LI, Lebel S, et al.

Cancer 2024; (130(16)):2739-2742 doi:10.1002/cncr.35326.

Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients.

Muto Y, Fujimura T, Takahashi A, et al.

The Journal of dermatology 2024; (51(9)):1225-1232 doi:10.1111/1346-8138.17280.

Metastatic Fibrosarcomatous Transformation of Dermatofibrosarcoma Protuberans With Lung Metastasis: A Case Report.

Khan S, Yetiskul E, Niazi M, et al.

Cureus 2024; (16(5)):e59742 doi:10.7759/cureus.59742.

Dermatofibrosarcoma Protuberans in a 12-Year-Old Child: A Rare Case.

Sutedja EK, Sutedja E, Ruchiatan K, et al.

Clinical, cosmetic and investigational dermatology 2024; (17()):1921-1930 doi:10.2147/CCID.S480616.

Dermatofibrosarcoma Protuberans: An Updated Review of the Literature.

Jozwik M, Bednarczuk K, Osierda Z

Cancers 2024; (16(18)) doi:10.3390/cancers16183124.

A Clinicopathological Study of 24 Cases of DFSP.

Kachi M, Hamahata A, Oashi K, et al.

Journal of plastic and reconstructive surgery 2025; (4(1)):26-32 doi:10.53045/jprs.2023-0052.

Pulmonary metastasis of dermatofibrosarcoma protuberans.

Cao Q, Zhang C, Li L, et al.

Pulmonology 2025; (31(1)):2498280 doi:10.1080/25310429.2025.2498280.

Immunohistochemical Profiles of Dermatofibroma and Dermatofibrosarcoma Protuberans: A Scoping Review.

Hardy CSC, Razavi A, Nunez N, et al.

Applied immunohistochemistry & molecular morphology : AIMM 2026; (34(1)):5-14 doi:10.1097/PAI.0000000000001284.

Contemporary Management of Dermatofibrosarcoma Protuberans.

Janczewski LM, Wayne JD

Hematology/oncology clinics of North America 2026; (40(1)):39-49 doi:10.1016/j.hoc.2025.07.004.

[Dermatofibrosarcoma protuberans].

Demouche S

Annales de chirurgie plastique et esthetique 2025; (70(6)):470-475 doi:10.1016/j.anplas.2025.05.012.

Fifth-Time Recurrence of Dermatofibrosarcoma Protuberans at Distinct Sites: A Rare Case Report.

Tariq H, Javed H, Amin MHJ

Clinical case reports 2025; (13(12)):e71636 doi:10.1002/ccr3.71636.